#sumitomopharma — Public Fediverse posts

A health ministry panel has approved healthcare coverage for Sumitomo Pharma's Parkinson's disease treatment Amchepry, making it the world's first commercialized medical product derived from iPS cells. https://www.japantimes.co.jp/news/2026/05/13/japan/science-health/ips-parkinsons-disease/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #mhlw #drugs #medicine #parkinson039sdisease #sumitomopharma #ips

A health ministry panel has approved healthcare coverage for Sumitomo Pharma's Parkinson's disease treatment Amchepry, making it the world's first commercialized medical product derived from iPS cells. https://www.japantimes.co.jp/news/2026/05/13/japan/science-health/ips-parkinsons-disease/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #mhlw #drugs #medicine #parkinson039sdisease #sumitomopharma #ips

A health ministry panel has approved healthcare coverage for Sumitomo Pharma's Parkinson's disease treatment Amchepry, making it the world's first commercialized medical product derived from iPS cells. https://www.japantimes.co.jp/news/2026/05/13/japan/science-health/ips-parkinsons-disease/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #mhlw #drugs #medicine #parkinson039sdisease #sumitomopharma #ips

A health ministry panel has approved healthcare coverage for Sumitomo Pharma's Parkinson's disease treatment Amchepry, making it the world's first commercialized medical product derived from iPS cells. https://www.japantimes.co.jp/news/2026/05/13/japan/science-health/ips-parkinsons-disease/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #mhlw #drugs #medicine #parkinson039sdisease #sumitomopharma #ips

A health ministry panel has given conditional approval to two medical products derived from iPS cells, paving the way for the world’s first commercialization of Nobel Prize-winning stem cell research. https://www.japantimes.co.jp/news/2026/02/20/japan/science-health/ips-cell-based-products/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #ips #parkinson039s #heartdisease #cuorips #sumitomopharma #health

Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings

Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings

Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings

Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings